ALYSSA CAPARELLI: Open Payments
NPI 1467198879 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,542 in 54 payments from 14 companies in 2025. Trend: 2023 $1,481 · 2024 $2,010 · 2025 $1,542
Food & beverage: $1,363Education: $179
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 11 | $624 |
| Janssen Biotech, Inc. | 9 | $257 |
| ABBVIE INC. | 10 | $168 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $85 |
| GENZYME CORPORATION | 3 | $85 |
| PFIZER INC. | 3 | $84 |
| Organon LLC | 4 | $56 |
| Biofrontera Inc. | 3 | $54 |
| MERZ NORTH AMERICA, INC. | 1 | $28 |
| Almirall LLC | 1 | $25 |
Products named: Bimzelx, TREMFYA, SKYRIZI, DUPIXENT, CIBINQO, VTAMA, ILUMYA, Winlevi.
Industry payments across NV — which companies pay providers there.
